Skip to main content

Exane Derivatives

SEC CIK
0001623883
Latest filing
Jul 12, 2022

HZNP holding history

Horizon Therapeutics Public Ltd Co in every 13F filed by Exane Derivatives, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HZNP overviewAll 13F holders of HZNPFull Q2 2022 holdings

Shares (Q2 2022)
1,017
Value
$81.1K
% of portfolio
<0.1%
Quarters held
2
Since Q1 2022
Holdings of HZNP by Exane Derivatives, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20221,017$81.1K<0.1%+439+76.0%AddedHolders
Q1 2022578$60.8K<0.1%+578NewHolders